AAAAAA
Results:
1-21
|
Results: 21
Authors:
Allred, DC
Mohsin, SK
Fuqua, SAW
Citation: Dc. Allred et al., Histological and biological evolution of human premalignant breast disease, ENDOCR-R CA, 8(1), 2001, pp. 47-61
Authors:
Zhou, J
Allred, DC
Avis, I
Martinez, A
Vos, MD
Smith, L
Treston, AM
Mulshine, JL
Citation: J. Zhou et al., Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer, BREAST CANC, 66(3), 2001, pp. 217-224
Authors:
Martin, MD
Fischbach, K
Osborne, CK
Mohsin, SK
Allred, DC
O'Connell, P
Citation: Md. Martin et al., Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene, CANCER RES, 61(9), 2001, pp. 3578-3580
Authors:
Allred, DC
Swanson, PE
Citation: Dc. Allred et Pe. Swanson, Testing for erbB-2 by immunohistochemistry in breast cancer, AM J CLIN P, 113(2), 2000, pp. 171-175
Authors:
Allred, DC
Medina, D
Citation: Dc. Allred et D. Medina, Introduction: Models of premalignant breast disease, J MAMMARY G, 5(4), 2000, pp. 339-340
Authors:
Allred, DC
Mohsin, SK
Citation: Dc. Allred et Sk. Mohsin, Biological features of premalignant disease in the human breast disease, J MAMMARY G, 5(4), 2000, pp. 351-364
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Makris, A
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients, CLIN CANC R, 6(2), 2000, pp. 616-621
Authors:
Zellars, RC
Hilsenbeck, SG
Clark, GM
Allred, DC
Herman, TS
Chamness, GC
Elledge, RM
Citation: Rc. Zellars et al., Prognostic value of p53 for local failure in mastectomy-treated breast cancer patients, J CL ONCOL, 18(9), 2000, pp. 1906-1913
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Clark, GM
Dowsett, M
Citation: J. Chang et al., Predictors of response to chemotherapy - In Reply, J CL ONCOL, 18(7), 2000, pp. 1601-1602
Authors:
Elledge, RM
Green, S
Pugh, R
Allred, DC
Clark, GM
Hill, J
Ravdin, P
Martino, S
Osborne, CK
Citation: Rm. Elledge et al., Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predictingresponse to tamoxifen in metastatic breast cancer: A Southwest Oncology Group Study, INT J CANC, 89(2), 2000, pp. 111-117
Authors:
Fuqua, SAW
Wiltschke, C
Zhang, QX
Borg, A
Castles, CG
Friedrichs, WE
Hopp, T
Hilsenbeck, S
Mohsin, S
O'Connell, P
Allred, DC
Citation: Saw. Fuqua et al., A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions, CANCER RES, 60(15), 2000, pp. 4026-4029
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma
Authors:
Chang, J
Ormerod, M
Powles, TJ
Allred, DC
Ashley, SE
Dowsett, M
Citation: J. Chang et al., Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma, CANCER, 89(11), 2000, pp. 2145-2152
Authors:
O'Connell, P
Fischbach, K
Hilsenbeck, S
Mohsin, SK
Fuqua, SAW
Clark, GM
Osborne, CK
Allred, DC
Citation: P. O'Connell et al., Loss of heterozygosity at D14S62 and metastatic potential of breast cancer, J NAT CANC, 91(16), 1999, pp. 1391-1397
Authors:
Diab, SG
Clark, GM
Osborne, CK
Libby, A
Allred, DC
Elledge, RM
Citation: Sg. Diab et al., Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas, J CL ONCOL, 17(5), 1999, pp. 1442-1448
Authors:
Harvey, JM
Clark, GM
Osborne, CK
Allred, DC
Citation: Jm. Harvey et al., Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer, J CL ONCOL, 17(5), 1999, pp. 1474-1481
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashey, SE
Clark, GM
Makris, A
Assersohn, L
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer, J CL ONCOL, 17(10), 1999, pp. 3058-3063
Authors:
Makris, A
Powles, TJ
Allred, DC
Ashley, SE
Trott, PA
Ormerod, MG
Titley, JC
Dowsett, M
Citation: A. Makris et al., Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study, BREAST CANC, 53(1), 1999, pp. 51-59
Authors:
Mohsin, SK
Allred, DC
Citation: Sk. Mohsin et Dc. Allred, Immunohistochemical biomarkers in breast cancer, J HISTOTECH, 22(3), 1999, pp. 249-261
Authors:
Allred, DC
Elledge, RM
Citation: Dc. Allred et Rm. Elledge, Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes, CANCER, 86(6), 1999, pp. 905-907
Authors:
Libby, AL
Zellars, RC
O'Connell, P
Allred, DC
Citation: Al. Libby et al., Biologic characteristics of premalignant breast disease, MOLECULAR PATHOLOGY OF EARLY CANCER, 1999, pp. 79-95
Authors:
Elledge, RM
Allred, DC
Citation: Rm. Elledge et Dc. Allred, Prognostic and predictive value of p53 and p21 in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 79-98
Risultati:
1-21
|